01-Jun-2022
Download PDF
Aurobindo Pharma
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing copies of newspaper advertisement of the financial results of the company for the 4th quarter and year ended March 31 2022 as published in Business Standard and Nava Telagana on June 1 2022.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
